Arbutus Biopharma (ABUS) Treasury Shares (2023)

Arbutus Biopharma (ABUS) posted quarterly Treasury Shares of $1.2 million for Q4 2023.

Arbutus Biopharma (ABUS) Treasury Shares (2023) Analysis & Trends

Arbutus Biopharma (ABUS) has reported Treasury Shares for 1 consecutive years, with $1.2 million the latest figure, recorded in Q4 2023.

Quarterly Treasury Shares changed N/A year-over-year to $1.2 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.2 million (changed N/A YoY) and the FY2023 annual result came in at $1.2 million, changed N/A from the prior year.
Treasury Shares steadied at $1.2 million in Q4 2023 per ABUS's latest filing.
Over the last five years, Treasury Shares for ABUS reached as high as $1.2 million in Q4 2023 and fell as low as $1.2 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-21,709.08
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	265,401.92
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	19.41 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	5.14 Mn
10	Arbutus Biopharma	880.36 Mn	785.13 Mn	-	-

Download Data

Date	Value
Dec 31, 2023	1.23 Mn
Dec 31, 2023	1.23 Mn